Maximilian Grant > Latham & Watkins LLP > Washington DC, United States > Lawyer Profile
Latham & Watkins LLP Offices
555 ELEVENTH STREET, NW, SUITE 1000
WASHINGTON DC 20004-1304
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Maximilian Grant
Position
Max Grant serves as trial counsel in patent infringement cases and provides strategic business counseling on intellectual property issues. He led Latham & Watkins’ Intellectual Property Litigation Practice from 2009-2014, a period during which the group more than doubled in size and won the Chambers USA Award for Excellence. The group’s strategic development and unique trial capabilities were featured in an article in The Recorder, an ALM publication. Mr. Grant has tried over 20 patent cases and is recognized as an experienced and innovative first chair trial lawyer.
Career
Lawyer Rankings
United States > Intellectual property > Patents: litigation (International Trade Commission)
Latham & Watkins LLP offers a team of experienced patent litigators with impressive ITC expertise, frequently representing major companies in high-profile litigation. Notable cases from the last year include achieving a favorable settlement for Jaguar Land Rover, successfully asserting five patents against The Chamberland Group on behalf of the Overhead Door Corporation, and representing Taiwan Semiconductor Manufacturing Company in an investigation linked to advanced semiconductor technology that is set to have industry-wide effects. Based in Washington DC, Bert Reiser and Jamie Underwood co-chair the ITC practice, both widely lauded for their expertise and litigious capabilities. Also based in Washington, Maximilian Grant, and Michael David are integral to the team, as is Douglas Lumish, who operates out of the firm’s Silicon Valley and San Francisco offices.
United States > Intellectual property > Patents: litigation (full coverage)
(Leading lawyers)The patent litigation team at Latham & Watkins LLP offers expertise across cross all aspects of intellectual property, evidenced by an impressive history of success for Fortune 100 and numerous blue-chip companies. The team is well-integrated and highly capable of handling complex disputes across jurisdictions, in district and federal court, the International Trade Commission, and the Patent Trial and Appeal Board. With experience across industries, the team regularly acts for major pharma companies, including Amgen, Biogen, Johnson & Johnson, Abbott Laboratories, Regeneron, and Eagle Pharmaceuticals. David Callahan from the firm’s Chicago office is the global chair of the practice, regularly acting as a first-chair trial lawyer. The global vice chairs include Tony Sammi in New York, Jeff Homrig in Austin, and Jennifer Barry in San Diego. In Silicon Valley, Douglas Lumish is a key lawyer in the team, frequently acting on high-profile and precedent-setting matters. Maximilian Grant and Matthew J. Moore in Washington DC are both integral figures, with extensive experience.
Lawyer Rankings
- Leading lawyers United States > Intellectual property > Patents: litigation (full coverage)
- Patents: litigation (full coverage) United States > Intellectual property
- Patents: litigation (International Trade Commission) United States > Intellectual property
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Real estate > Land use/zoning
- Environment > Environment: transactional
- Environment > Environment: transactional
- Real estate > Land use/zoning
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Real estate > Land use/zoning
- Environment > Environment: transactional
- Environment > Environment: litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- Environment > Environment: regulatory
- Media, technology and telecoms > Outsourcing
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Environment > Environment: regulatory
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- International Trade > CFIUS
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > Financial services litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Healthcare > Service providers
- Finance > Structured finance: securitization
- International Trade > Customs, export controls and economic sanctions
- Government > Government contracts
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Intellectual property > Trademarks: litigation
- Dispute resolution > International arbitration
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)